.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Merck
Argus Health
Johnson and Johnson
Express Scripts
Cerilliant
Julphar
Colorcon
Deloitte

Generated: September 23, 2017

DrugPatentWatch Database Preview

Rocuronium bromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rocuronium bromide and what is the scope of rocuronium bromide patent protection?

Rocuronium bromide
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Organon Usa Inc, Tamarang, Teva Pharms, Hospira, Fresenius Kabi Usa, Sagent Pharms, West Ward Pharm Corp, Sandoz Inc, and Mylan Institutional, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for rocuronium bromide. Twelve suppliers are listed for this compound.

Summary for Generic Name: rocuronium bromide

Tradenames:2
Patents:0
Applicants:10
NDAs:10
Drug Master File Entries: see list11
Suppliers / Packagers: see list12
Bulk Api Vendors: see list44
Clinical Trials: see list532
Patent Applications: see list359
Drug Prices:see low prices
DailyMed Link:rocuronium bromide at DailyMed

Pharmacology for Ingredient: rocuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION079199-002Nov 26, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION079199-001Nov 26, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION206206-002Apr 12, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
West Ward Pharm Corp
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION204679-002Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-003Mar 17, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Tamarang
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION091115-001Aug 27, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION091458-001Jul 28, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION078717-001Nov 26, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION079195-002Dec 5, 2008APRXNoYes► Subscribe► Subscribe► Subscribe
Hospira
ROCURONIUM BROMIDE
rocuronium bromide
INJECTABLE;INJECTION078519-002Nov 26, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: rocuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-001Mar 17, 1994► Subscribe► Subscribe
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-003Mar 17, 1994► Subscribe► Subscribe
Organon Usa Inc
ZEMURON
rocuronium bromide
INJECTABLE;INJECTION020214-002Mar 17, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Julphar
AstraZeneca
Farmers Insurance
UBS
Argus Health
Healthtrust
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot